Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns
Go back to Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 206.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $206.63 | 52 Week High | $333.65 | |||
| Open | $206.63 | 52 Week Low | $223.02 | |||
| Day High | $206.63 | P/E | 26.46 | |||
| Day Low | $206.63 | EPS | $7.81 | |||
| Volume | 43 | |||||
